CLEVELAND and BOSTON – Cleveland Clinic and Amwell® (NYSE: AMWL) today announced the appointment of new leadership to their digital health company, a joint venture that delivers virtual care from Cleveland Clinic’s highly specialized team of clinical experts through Amwell’s technology platform. Egbert van Acht will assume the position of Executive Vice Chairman to the Board of Directors and Frank McGillin will lead as CEO.
“Telemedicine continues to play a pivotal role in offering safe and accessible care to patients, especially during the COVID-19 pandemic where the need for virtual access to care has significantly increased,” said William Peacock, Chairman of the Board of Cleveland Clinic/Amwell joint venture and Chief of Operations at Cleveland Clinic. “The addition of Egbert and Frank to our leadership team reinforces the importance of making digital health a core part of our care delivery model, so more patients can access the healthcare services they need in convenient ways.”
Formed one year ago as a first-of-its-kind company to provide broad access to comprehensive, high-acuity care via telehealth, the company has made great progress scaling digital care through its MyConsult® offering. With an initial focus on clinical second opinions, the organization also offers health information and diagnosis on more than 2,000 different types of conditions including cancer, cardiac, and neuroscience issues.
“The Amwell and Cleveland Clinic teams have come together in a swift, pragmatic way to build upon the successes that Cleveland Clinic has modeled in digital care over the years,” said Ido Schoenberg, Chairman and Co-CEO, Amwell. “The impact of services delivered to date are already proving to guide and enhance patients’ health journeys. Under Frank and Egbert’s leadership, we’re excited to see that impact scale, bringing the world’s best care to new and necessary places.”
Frank McGillin, CEO of the Cleveland Clinic/Amwell joint venture said, “The mission of helping patients get the best care possible and addressing the big healthcare issues has driven me throughout my career. By leveraging Cleveland Clinic’s medical excellence and Amwell’s virtual care technology, I have every confidence that this organization will drive better health outcomes around the world.”
Egbert van Acht, Executive Vice Chairman to the Board of Directors for the joint venture added, “Based on the current, strong momentum for telehealth I see a global opportunity to provide a unique, superior, and safe consumer and patient experience. Cleveland Clinic’s clinical excellence can be brought to every individual in the world now via the Amwell platform, channels, and technology which makes this a very exciting opportunity.”
van Acht and McGillin bring decades of experience and success from their time spent leading global organizations that focused on consumer brands and the adoption of health and medical services and behaviors.
van Acht’s experience at Royal Philips, where he served as Executive Vice President and CEO of the Personal Health Business, in addition to his experience at Procter & Gamble, position him to help the company in global innovation, marketing and sales strategy, partnerships and customer acquisition.
Likewise, McGillin’s most recent position as Senior Vice President and Chief Commercial Officer at NeuroMetrix, in addition to his roles at Philips Healthcare, reinforce his ability to drive day-to-day operational activity, team and management excellence, and go-to-market strategy and execution that will advance the company across global consumer, health plan, and employer audiences.
To learn more about the Cleveland Clinic/Amwell joint venture and its services, please visit: https://go.myconsult2020.com/
To learn more about second opinion patient stories, please visit: To https://my.clevelandclinic.org/patient-stories/405-online-second-medical-opinion-confirms-diagnosis-and-treatment-plan
Amwell: Holly Spring, Amwell Holly.firstname.lastname@example.org,781.888.8219
Cleveland Clinic: Tora Vinci, 216.339.4277, email@example.com